Celecoxib potentiates ribociclib-induced apoptosis and anti-tumor activity by co-targeting COX-2/NF-κB and PI3K/AKT/mTOR pathways in hormone receptor-positive/HER2-negative breast cancer. - Han S; Kim H; Choi M; Kim BH; Chae S; Lee SG (Apoptosis : an international journal on programmed cell death, 2026)